Last reviewed · How we verify

NCT05979116

Effect of Abdominal Myofascial Release on Pain and Functional Outcomes of Neck in Females with Cesarean Section

Completed NA Last updated 19 December 2024
What this trial tests

NA trial testing myofascial release in Cesarean Section in 30 participants. Completed in 30 May 2024.

Timeline
1 August 2023
Primary endpoint
20 February 2024
30 May 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 August 2023
Primary completion20 February 2024
Estimated completion30 May 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 35, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effect of abdominal myofascial release on pain, ROM and functional abilities of neck in females with CS scar.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of myofascial release

Trials testing the same drug.

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05979116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing